Exploring Kiniksa Pharmaceuticals's Earnings Expectations
Portfolio Pulse from Benzinga Insights
Kiniksa Pharmaceuticals (NASDAQ:KNSA) is set to announce its quarterly earnings on October 29, 2024. Analysts expect an EPS of $0.02. The company's past performance shows mixed results, with a notable 4.15% share price drop after the last earnings beat. Kiniksa's stock has risen 81.11% over the past year, and it holds a 'Buy' rating with a $40 price target, suggesting a 45.77% upside. Despite positive revenue growth, Kiniksa ranks low among peers in key financial metrics.
October 28, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Kiniksa Pharmaceuticals is expected to announce its quarterly earnings with an EPS estimate of $0.02. The stock has shown significant volatility post-earnings in the past, and investors will be keen on the company's guidance. Despite a strong stock performance over the past year, Kiniksa ranks low among peers in key financial metrics.
The upcoming earnings announcement is crucial for Kiniksa Pharmaceuticals, with an EPS estimate of $0.02. The stock has shown volatility after past earnings, and guidance will be a key factor for short-term price movement. Despite a strong year-over-year stock performance, the company ranks low among peers in financial metrics, which could temper investor enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100